Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Merrimack Pharmaceuticals Inc (MACK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	03-2014	12-2013	09-2013	06-2013	03-2013
Assets
Current Assets
Cash & Cash Equivalents	66,998	65,187	105,552	31,043	28,535
Marketable Securities	57,279	90,116	77,034	31,197	58,252
Receivables	12,155	5,857	8,835	14,537	9,798
TOTAL	$138,882	$166,644	$200,281	$85,947	$106,752

Non-Current Assets
PPE Net	13,779	13,364	11,468	8,155	7,307
Intangibles	11,570	11,650	11,730	12,620	12,700
Other Non-Current Assets	751	759	764	598	562
TOTAL	$26,100	$25,773	$23,962	$21,373	$20,569

Total Assets	$164,982	$192,417	$224,243	$107,320	$127,321

Liabilities
Current Liabilities
Short Term Debt	12,022	8,248	6,376	9,970	6,254
Accounts payable and accrued liabilities	34,110	38,814	42,913	36,322	31,184
Other current liabilities	1,330	1,336	2,234	2,119	1,474
TOTAL	$56,989	$57,734	$60,859	$57,747	$48,314

Non-Current Liabilities
Long Term Debt	101,789	103,427	34,379	30,592	34,076
Deferred Revenues	9,527	9,336	9,336	9,336	8,890
Other Non-Current Liabilities	7,803	7,364	79,008	8,767	8,105
TOTAL	$173,957	$178,148	$179,645	$107,914	$111,147

Total Liabilities	$230,946	$235,882	$240,504	$165,661	$159,461

Shareholders' Equity
Shares Outstanding, K	10,341	10,304	10,235	10,221	9,609
Common Shares	1,034	1,025	1,023	964	959
Retained earnings	-599,830	-572,245	-539,982	-500,351	-470,269
Other shareholders' equity	-8	-24	-16	-247	-93
TOTAL	$-65,964	$-43,465	$-16,261	$-58,341	$-32,140

Total Liabilities And Equity	$164,982	$192,417	$224,243	$107,320	$127,321